Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

87 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Exploiting nanopore sequencing for characterization and grading of IDH-mutant gliomas.
Wongsurawat T, Jenjaroenpun P, Anekwiang P, Arigul T, Thongrattana W, Jamshidi-Parsian A, Boysen G, Suriyaphol P, Suktitipat B, Srirabheebhat P, Cheunsuchon P, Tanboon J, Nookaew I, Sathornsumetee S. Wongsurawat T, et al. Among authors: sathornsumetee s. Brain Pathol. 2024 Jan;34(1):e13203. doi: 10.1111/bpa.13203. Epub 2023 Aug 13. Brain Pathol. 2024. PMID: 37574201 Free PMC article.
New approaches to primary brain tumor treatment.
Sathornsumetee S, Rich JN. Sathornsumetee S, et al. Anticancer Drugs. 2006 Oct;17(9):1003-16. doi: 10.1097/01.cad.0000231473.00030.1f. Anticancer Drugs. 2006. PMID: 17001172 Review.
Phase I trial of irinotecan plus temozolomide in adults with recurrent malignant glioma.
Reardon DA, Quinn JA, Rich JN, Desjardins A, Vredenburgh J, Gururangan S, Sathornsumetee S, Badruddoja M, McLendon R, Provenzale J, Herndon JE 2nd, Dowell JM, Burkart JL, Newton HB, Friedman AH, Friedman HS. Reardon DA, et al. Among authors: sathornsumetee s. Cancer. 2005 Oct 1;104(7):1478-86. doi: 10.1002/cncr.21316. Cancer. 2005. PMID: 16088964 Free article. Clinical Trial.
Phase 1 trial of dasatinib plus erlotinib in adults with recurrent malignant glioma.
Reardon DA, Vredenburgh JJ, Desjardins A, Peters KB, Sathornsumetee S, Threatt S, Sampson JH, Herndon JE 2nd, Coan A, McSherry F, Rich JN, McLendon RE, Zhang S, Friedman HS. Reardon DA, et al. Among authors: sathornsumetee s. J Neurooncol. 2012 Jul;108(3):499-506. doi: 10.1007/s11060-012-0848-x. Epub 2012 Mar 10. J Neurooncol. 2012. PMID: 22407177 Free PMC article. Clinical Trial.
Molecularly targeted therapy for malignant glioma.
Sathornsumetee S, Reardon DA, Desjardins A, Quinn JA, Vredenburgh JJ, Rich JN. Sathornsumetee S, et al. Cancer. 2007 Jul 1;110(1):13-24. doi: 10.1002/cncr.22741. Cancer. 2007. PMID: 17520692 Free article. Review.
Targeting cancer stem cells through L1CAM suppresses glioma growth.
Bao S, Wu Q, Li Z, Sathornsumetee S, Wang H, McLendon RE, Hjelmeland AB, Rich JN. Bao S, et al. Among authors: sathornsumetee s. Cancer Res. 2008 Aug 1;68(15):6043-8. doi: 10.1158/0008-5472.CAN-08-1079. Cancer Res. 2008. PMID: 18676824 Free PMC article.
Safety and pharmacokinetics of dose-intensive imatinib mesylate plus temozolomide: phase 1 trial in adults with malignant glioma.
Reardon DA, Desjardins A, Vredenburgh JJ, Sathornsumetee S, Rich JN, Quinn JA, Lagattuta TF, Egorin MJ, Gururangan S, McLendon R, Herndon JE 2nd, Friedman AH, Salvado AJ, Friedman HS. Reardon DA, et al. Among authors: sathornsumetee s. Neuro Oncol. 2008 Jun;10(3):330-40. doi: 10.1215/15228517-2008-003. Epub 2008 Mar 21. Neuro Oncol. 2008. PMID: 18359865 Free PMC article. Clinical Trial.
Neurofibromatosis type 2.
Sathornsumetee S, DesJardins A, Reardon DA, Rich JN, Vredenburgh JJ. Sathornsumetee S, et al. Neurology. 2007 Mar 27;68(13):E14. doi: 10.1212/01.wnl.0000257828.56178.9f. Neurology. 2007. PMID: 17389295 No abstract available.
87 results